Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion

Technology appraisal guidance
Reference number: TA229
Published: 27 July 2011

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders
17 November 2014
(36.3 Kb 10 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 17 November 2014